About the Symposium
We are thrilled to invite you to the inaugural Transforming Health Symposium on November 4, 2024, presented by the UBC Academy of Translational Medicine (ATM), the UBC Faculty of Medicine’s Precision Health Initiative, and Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH).
This event will bring together a community of global thought leaders, clinicians, investigators, trainees and industry experts to examine the translational pathway highlighting areas of excellence locally and beyond. Whether speakers are participating in a keynote presentation, panel or showcase they will stimulate engaging conversations on elevating the regional capacity for translational medicine and provide inspiring insights for new ways forward towards transforming health for all.
Registration is required to secure your seat. Spaces will be limited and first-come, first-serve.
Event details
Date: November 4, 2024
Location: Vancouver Convention Centre, 1055 Canada Pl, Vancouver BC
Time: 8:00 am–7:00 pm Pacific Time; registration from 8:00–8:30 am
Cost: Free
Keynote speaker: Professor Graham Lord
BA MB BChir MA PhD FRCP FRSB FMedSci, NIHR Senior Investigator Emeritus
Graham Lord is the Senior Vice-President, Health & Life Sciences, King’s College London (KCL), Executive Director, King’s Health Partners (an Academic Health Science Center) and Chief Academic Officer & Board Director, Guy’s & St. Thomas’ and King’s College Hospital NHS Foundation Trusts. He was previously Vice-President at the University of Manchester and Dean of the Faculty of Biology, Medicine and Health, a Consultant Transplant Nephrologist at Manchester NHS Foundation Trust and Executive Director of the Manchester Academic Health Science Centre (2019-2024).
Before joining the University of Manchester in 2019, he held the position of Professor of Medicine and Head of the Department of Experimental Immunobiology and Director of the NIHR Biomedical Research Centre at King’s College London. He has raised >$40m as a Principal Investigator, >$450 in UK Governmental Research Center Awards and >$1bn in VC and public capital market funding.
A leading clinician-scientist, Prof Lord trained in Medicine at the University of Cambridge, gained a PhD at Imperial College London and completed his postdoctoral training at Harvard University. He then established a research group seeking to understand the regulation of the immune system to enhance the treatment of severe inflammatory diseases. His clinical interest is in multi-organ transplantation and the genetics of long-term transplant failure. He has significant commercial expertise, having founded companies in the US that focus on immuno-oncology, infectious diseases and autoimmunity and has recently graduated from the Advanced Management Program at Harvard Business School.